Advances in Use of Endoscopy, Radiology, and Biomarkers to Monitor Inflammatory Bowel Diseases
Authors:
- 1 January 2017
- journal article
- review article
- Published by Elsevier in Gastroenterology
- Vol. 152 (2) , 362-373.e3
Abstract
No abstract availableKeywords
Funding Information
- Ministerio de Economía y Competitividad
This publication has 115 references indexed in Scilit:
- Perception gaps between patients with ulcerative colitis and healthcare professionals: an online surveyBMC Gastroenterology, 2012
- Endoscopic improvement of mucosal lesions in patients with moderate to severe ileocolonic Crohn's disease following treatment with certolizumab pegolGut, 2012
- Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)Gut, 2011
- Development of the Crohnʼs disease digestive damage score, the Lémann scoreInflammatory Bowel Diseases, 2011
- Infliximab, Azathioprine, or Combination Therapy for Crohn's DiseaseNew England Journal of Medicine, 2010
- Influence of Genetic Variation in the C‐Reactive Protein Gene on the Inflammatory Response During and After Acute Coronary IschemiaAnnals of Human Genetics, 2006
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001
- Colonoscopy of acute colitisDigestive Diseases and Sciences, 1994
- Endosonography of peri-anal and pericolorectal fistula and/or abscess in Crohn’s diseaseGastrointestinal Endoscopy, 1990
- Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative ColitisNew England Journal of Medicine, 1987